UPGRADES/DOWNGRADES
DATE CATEGORY ANALYST FIRM INFO 5/14/2024 Downgrades Piper Sandler 5/14/2024 Maintains Cantor Fitzgerald AVITA Medical Stock (NASDAQ:RCEL), Analyst Ratings, Price Targets, Predictions
AVITA Medical Inc has a consensus price target of $19.4, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Cantor Fitzgerald, and BTIG on May 14, 2024, May 14, 2024, and April 11, 2024. With an average price target of $10 between Piper Sandler, Cantor Fitzgerald, and BTIG, there's an implied 16.96% upside for AVITA Medical Inc from these 3 analyst ratings.
UPGRADES/DOWNGRADESDATECATEGORYANALYST...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.330(12.4%) |
Mkt cap ! $185.9M | |||
| Open | High | Low | Value | Volume |
| $3.04 | $3.17 | $2.95 | $5.283M | 1.752M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5991 | $2.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 12281 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.99 |
Change
0.330 ( 12.2 %) |
||||
| Open | High | Low | Volume | ||
| $3.10 | $3.10 | $2.95 | 117225 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| AVH (ASX) Chart |